A team led by researchers at the Warsaw University of Technology have developed a promising new approach to studying tRNA modifications using Oxford Nanopore Sequencing (ONS). While ONS has been widely used to study mRNA, its application to transfer RNA (tRNA), which carries amino acids during protein synthesis, has been limited due to the complexity of tRNA structures and modifications.
One of the biggest challenges in the field has been detecting modifications at uridine 34 (U34) in the anticodon loop of tRNA, a site that carries some of the most chemically complex changes. These modifications play a critical role in translation and, when faulty, are linked to some of the most severe human diseases. Until now, there haven’t been effective tools to monitor these subtle yet impactful changes at single-transcript resolution.
To overcome this limitation, the team synthesized modified tRNA molecules containing either xcm5U or xcm5s2U, two chemically altered forms of uridine, and used ONS to test whether these modifications could be distinguished. Remarkably, ONS was able to pick up distinct signal features from both types of uridine, even when only a single modification was present. The presence or absence of a thiol group (s2U) on uridine significantly influenced the sequencing signal, providing a reliable fingerprint for each modification.
Unlocking Diagnostic Potential for tRNA-Related Diseases
This breakthrough opens new doors for understanding the dynamic role of tRNA modifications in both healthy cells and disease states. Since modifications at U34 are linked to a group of life-threatening diseases, being able to detect and analyze them accurately could lead to new diagnostic tools and possibly even targeted therapies.
The application of ONS in this way not only expands our understanding of RNA biology but also provides a cost-effective and scalable method to study some of the most elusive molecular features in cells. As this technique is refined, it may become a key tool in personalized medicine and disease monitoring.
Kusmirek W, Strozynska N, Martin-Arroyo Cerpa P, Dziergowska A, Leszczynska G, Nowak R, Adamczyk M. (2025) Direct RNA Oxford Nanopore sequencing distinguishes between modifications in tRNA at the U34 position. Int J Biol Macromol 320(Part 2):145877. [article]
Related Posts
A team led by researchers at the Warsaw University of Technology have developed a promising new approach to studying tRNA modifications using Oxford Nanopore Sequencing (ONS). While ONS has been widely used to study mRNA, its application to transfer RNA (tRNA), which carries amino acids during protein synthesis, has been limited due to the complexity of tRNA structures and modifications.
One of the biggest challenges in the field has been detecting modifications at uridine 34 (U34) in the anticodon loop of tRNA, a site that carries some of the most chemically complex changes. These modifications play a critical role in translation and, when faulty, are linked to some of the most severe human diseases. Until now, there haven’t been effective tools to monitor these subtle yet impactful changes at single-transcript resolution.
To overcome this limitation, the team synthesized modified tRNA molecules containing either xcm5U or xcm5s2U, two chemically altered forms of uridine, and used ONS to test whether these modifications could be distinguished. Remarkably, ONS was able to pick up distinct signal features from both types of uridine, even when only a single modification was present. The presence or absence of a thiol group (s2U) on uridine significantly influenced the sequencing signal, providing a reliable fingerprint for each modification.
Unlocking Diagnostic Potential for tRNA-Related Diseases
This breakthrough opens new doors for understanding the dynamic role of tRNA modifications in both healthy cells and disease states. Since modifications at U34 are linked to a group of life-threatening diseases, being able to detect and analyze them accurately could lead to new diagnostic tools and possibly even targeted therapies.
The application of ONS in this way not only expands our understanding of RNA biology but also provides a cost-effective and scalable method to study some of the most elusive molecular features in cells. As this technique is refined, it may become a key tool in personalized medicine and disease monitoring.
Kusmirek W, Strozynska N, Martin-Arroyo Cerpa P, Dziergowska A, Leszczynska G, Nowak R, Adamczyk M. (2025) Direct RNA Oxford Nanopore sequencing distinguishes between modifications in tRNA at the U34 position. Int J Biol Macromol 320(Part 2):145877. [article]
Related Posts
Recent Posts
Scientists identify the neuroblastoma cells that signal poor outcomes
GARAGE improves rare cell detection in single-cell RNA sequencing analysis using AI
Machine learning reveals how RNA splicing is regulated in individual cell types
Illumina releases SpliceAI2 to help advance rare disease research
Postdoctoral Fellow – Long-Read RNA Methods Development for Neurodegeneration
Novel biosensor uses DNA ‘barcodes’ to uncover disease signals in cells
RNA-Seq Products & Services
Stay Connected